Titan Nutrition CO
HELIXIR PHARMACEUTICALS - SEMAGLUTIDE (GLP-1 RECEPTOR AGONIST) 5mg
HELIXIR PHARMACEUTICALS - SEMAGLUTIDE (GLP-1 RECEPTOR AGONIST) 5mg
Couldn't load pickup availability
Advanced GLP-1 Agonist for Appetite Control & Metabolic Optimization
Prolonged-acting GLP-1 receptor agonist for advanced appetite control and metabolic regulation. It acts by enhancing natural signs of satiety and improving metabolic efficiency.
✓ Sustained reduction of appetite and effective craving control
✓ Improved insulin sensitivity and glycemic regulation
✓ Protection of muscle mass during caloric deficit
✓ Protection of muscle mass during caloric deficit
✓ Support for metabolic management in body recomposition protocols
MAIN ACTION
It acts on GLP-1 receptors in the central nervous system and pancreas, enhancing satiety signals, reducing the rate of gastric emptying and improving insulin sensitivity for integral metabolic control.
RESULTS IN RESEARCH
QUALITY AND ORIGIN
Purity greater than 99%, verified by HPLC analysis. Synthesized under pharmaceutical standards in US laboratories. USA
FACT SHEET
MOLECULAR STRUCTURE
Sequence: 37 amino acid peptide, human GLP-1 analogue
Molecular weight: Modified with fatty acid acylation (C18) for reversible bonding to albumin
PHARMACOKINETICS
Half-life: ~7 days
Bioavailability: High (subcutaneous)
Metabolism: Limited proteolysis; reversible binding to serum albumin that prolongs its half-life
Elimination: Mainly renal and fecal
USE AND ADMINISTRATION (RESEARCH)
Route: Subcutaneous (injection)
Dose in study: 5 mg per application
Frequency: 1 time per week
Presentation: Lyophilized bottle 5 mg
MECHANISM OF ACTION IN KEY SYSTEMS
Central nervous system
Decreases appetite and caloric intake, increasing satiety.
Pancreas
Improves cell beta function and reduces glucagon secretion.
Stomach
Delays gastric emptying, increasing the feeling of satiety.
Liver
Improves insulin sensitivity and reduces hepatic glucose production.
Adipose tissue
Reduces fat accumulation and improves lipid use.
Muscle
Increases glucose capture and improves energy metabolism.
AREAS OF APPLICATION IN RESEARCH
✓ Type 2 diabetes mellitus✓ Obesity and overweight
✓ Metabolic syndrome
✓ Non-alcoholic steatohepatitis (investigated)
✓ Cardiovascular prevention in high-risk patients
WARNINGS AND SECURITY
⚠ Use outside the indication according to current regulations.⚠ Product intended exclusively for health professionals and authorized centers.
Share
